BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37839048)

  • 1. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.
    Masuda Y; Yeo MHX; Burdio F; Sanchez-Velazquez P; Perez-Xaus M; Pelegrina A; Koh YX; Di Martino M; Goh BKP; Tan EK; Teo JY; Romano F; Famularo S; Ferrari C; Griseri G; Piardi T; Sommacale D; Gianotti L; Molfino S; Baiocchi G; Ielpo B
    Updates Surg; 2024 Jan; 76(1):57-69. PubMed ID: 37839048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.
    Tian Y; Wang Y; Wen N; Lin Y; Liu G; Li B
    Front Oncol; 2024; 14():1395740. PubMed ID: 38854717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.
    Liu L; Zhang J; Zhao K; Guo C; Huang C; Li S; Chen Y
    Orphanet J Rare Dis; 2024 Jun; 19(1):232. PubMed ID: 38863016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution.
    Vaghiri S; Prassas D; Mustafov O; Kalmuk S; Knoefel WT; Lehwald-Tywuschik N; Alexander A; Dizdar L
    BMC Surg; 2024 Apr; 24(1):101. PubMed ID: 38589847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms incorporating hsa_circ_0029325 highly expressed in exosomes of hepatocellular carcinoma predict the postoperative outcomes.
    Yin KL; Sun T; Duan YX; Ye WT; Ming Li ; Liao R
    Discov Oncol; 2024 Jun; 15(1):212. PubMed ID: 38836972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients.
    Chen L; Dhoomun DK; Liu Q; Kong X; Li X; Peng S; Lan P; Wang J
    Int Immunopharmacol; 2024 Jun; 137():112411. PubMed ID: 38852520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcopenia impacts treatment outcomes for Barcelona Cancer Liver Classification stage A hepatocellular carcinoma.
    Abe K; Furukawa K; Matsumoto M; Futagawa Y; Shiozaki H; Onda S; Haruki K; Shirai Y; Okamoto T; Ikegami T
    Surg Oncol; 2024 Apr; 53():102043. PubMed ID: 38330806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study.
    Yang J; Qian J; Wu Z; Zhang W; Yin Z; Shen W; He K; He Y; Liu L
    Cancer Med; 2024 Feb; 13(3):e6933. PubMed ID: 38284881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma.
    Huang XW; Li Y; Jiang LN; Zhao BK; Liu YS; Chen C; Zhao D; Zhang XL; Li ML; Jiang YY; Liu SH; Zhu L; Zhao JM
    Transl Oncol; 2024 Jul; 45():101986. PubMed ID: 38723299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1.
    He M; Liang C; Pang Y; Jiang M; Long M; Yao Z; Wang X; Zhang R; Wu Q; Liang S; Li J
    J Hepatocell Carcinoma; 2024; 11():913-925. PubMed ID: 38799002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
    Han CL; Tian BW; Yan LJ; Ding ZN; Liu H; Mao XC; Tian JC; Xue JS; Tan SY; Dong ZR; Yan YC; Hong JG; Chen ZQ; Wang DX; Li T
    Cancer Immunol Immunother; 2023 Jul; 72(7):1957-1969. PubMed ID: 36811662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram and calculator for predicting the prognosis of patients with giant hepatocellular carcinoma.
    Chen W; Cheng S
    Expert Rev Anticancer Ther; 2024 Jun; ():1-8. PubMed ID: 38874538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of macrotrabecular-massive hepatocellular carcinoma by using MR-based models and their prognostic implications.
    Chai F; Ma Y; Feng C; Jia X; Cui J; Cheng J; Hong N; Wang Y
    Abdom Radiol (NY); 2024 Feb; 49(2):447-457. PubMed ID: 38042762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nomogram based on the clinicopathological and CT features to predict the survival of primary pulmonary lymphoepithelial carcinoma patients.
    Nie K; Zhu L; Zhang Y; Chen Y; Parrington J; Yu H
    Respir Res; 2024 Mar; 25(1):144. PubMed ID: 38553718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic stratification of patients with pT4bN0M0 colorectal cancer following multivisceral resection: a multi-institutional case series analysis.
    Quan J; Zuo K; Li G; Liu J; Mei S; Hu G; Qiu W; Zhuang M; Meng L; Wang X; Chang H; Tang J
    Int J Surg; 2024 May; ():. PubMed ID: 38768462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study.
    Zuo M; Jiang H; Li W; Zhuo S; Wu P; An C
    Int J Surg; 2024 Jun; ():. PubMed ID: 38833331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
    Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
    Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice.
    Kim N; Yu JI; Park HC; Hong JY; Lim HY; Goh MJ; Paik YH
    J Liver Cancer; 2023 Sep; 23(2):350-361. PubMed ID: 37670423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis.
    Jin D; Qian L; Chen J; Yu Z; Dong J
    Medicine (Baltimore); 2024 Apr; 103(16):e37834. PubMed ID: 38640338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Versus Classical Approach During Right Hepatectomy for Hepatocellular Carcinoma: Inverse Propensity Score Weighted Analysis.
    Rhaiem R; Sommacale D; Zimmermann P; Amroun K; Tashkandi A; Laurent A; Amaddeo G; Calderaro J; Luciani A; Heurgue A; Thiefin G; Piardi T; Kianmanesh R; Brustia R
    J Gastrointest Surg; 2023 Oct; 27(10):2092-2102. PubMed ID: 37407897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.